Quick Answer
HCW Biologics Inc. reported Total Assets of $24.52 million for the year ending 2025.
- HCW Biologics Inc. showed a decrease of -18.9% in Total Assets from 2024 to 2025.
- This data is from HCW Biologics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $13.03 million | Q3 2021: $56.41 million | Q1 2022: $50.96 million | Q2 2022: $47.41 million | Q3 2022: $51.35 million | Q1 2023: $43.53 million | Q2 2023: $39.48 million | Q3 2023: $35.62 million | Q1 2024: $30.43 million | Q2 2024: $26.82 million | Q3 2024: $26.56 million | Q1 2025: $26.29 million | Q2 2025: $28.91 million | Q3 2025: $25.45 million.
- Over the full 6 years of available data (2020 to 2025), HCW Biologics Inc.'s Total Assets has grown by 59.2%.
- Historical annual values: Fiscal year 2025: $24.52 million | Fiscal year 2024: $30.24 million | Fiscal year 2023: $28.51 million | Fiscal year 2022: $46.81 million | Fiscal year 2021: $53.51 million | Fiscal year 2020: $15.40 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: